Live Breaking News & Updates on Laurent schots

Stay informed with the latest breaking news from Laurent schots on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Laurent schots and stay connected to the pulse of your community

UCB : Acquisition of own shares - MarketScreener

Regulated information

In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, UCB SA/NV hereby discloses...

Belgium , Brussels , Bruxelles-capitale , Belgian , Laurent-schots , Antje-witte , Corporate-communications , Share-repurchase-program , Belgian-code-on-companies , Company-euronext-brussels , Twitter , Royal-decree

UCB : General Meeting of Shareholders 2024

UCB's General Meeting of Shareholders 2024

For financial year 2023: Gross dividend of € 1.36 per share , payable 30 May 2024

...

Brussels , Bruxelles-capitale , Belgium , Charles-antoine-janssen , Laurent-schots , Pierre-gurdjian , Jean-christophe-tellier , Dolca-thomas , Bert-de-graeve , Ulf-wiinberg , Kay-davies , Rodolfo-savitzky

UCB : receives European Commission approval for BIMZELX▼(bimekizumab) as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa

UCB receives European Commission approval for BIMZELX[®]▼ as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa

...

Germany , Ireland , Brussels , Bruxelles-capitale , Belgium , Eimear-obrien , Antje-witte , Klinikum-dessau , Laurent-schots , Barry-mcgrath , Emmanuel-caeymaex , J-clin-pharmacol

UCB : presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology (AAN) Annual Meeting -April 12, 2024 at 01:05 am EDT

UCB presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology Annual Meeting

Diverse and...

Brussels , Bruxelles-capitale , Belgium , Colorado , United-states , Denver , American , Laurent-schots , Daphne-teo , Nick-francis , Donatello-crocetta , Becky-malone

UCB : Acquisition of own shares - 2024 -April 06, 2024 at 03:58 am EDT

Regulated information

Acquisition of own shares

In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies...

Belgium , Belgian , Laurent-schots , Antje-witte , Corporate-communications , Belgian-code-on-companies , Company-euronext-brussels , Share-repurchase-program , Royal-decree , Belgian-code , Euronext-brussels , Term-incentive-plans

UCB : FDA Accepts Supplemental Biologics License Applications for BIMZELX (bimekizumab-bkzx) for Moderate to Severe Hidradenitis Suppurativa and Additional 2mL Device Presentations -April 04, 2024 at 01:04 am EDT

FDA Accepts Supplemental Biologics License Applications for BIMZELX[®] for Moderate to Severe Hidradenitis Suppurativa and Additional 2mL Device Presentations

...

Belgium , Brussels , Bruxelles-capitale , Antje-witte , J-clin-pharmacol , Laurent-schots , Eimear-obrien , Emmanuel-caeymaex , European-union , Drug-administration , Immunology-solutions , Brand-communications

UCB : Share Repurchase Program 2024 to cover UCB's Long Term Incentive Plans for employees -March 29, 2024 at 03:04 pm EDT

Regulated information

In application of article 7:215 of the Belgian Code of Companies and Associations, UCB SA/NV announces the launch of a share buy-back program , effective...

Belgium , Belgian , Antje-witte , Laurent-schots , Company-euronext-brussels , Belgian-code-of-companies , Corporate-communications , Share-repurchase-program , During-the-share-repurchase-program , Belgian-code , Euronext-brussels , Repurchase-program

UCB on Growth Path for a Decade Plus

UCB on Growth Path for a Decade Plus
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Brussels , Bruxelles-capitale , Belgium , Japan , Julien-bayet , Laurent-schots , Jean-christophe-tellier , Antje-witte , Sandrine-dufour , Global-communications , European-medicines-agency , Amgen

ZILBRYSQ® (zilucoplan) Is Now Commercially Available in the U.S. for the Treatment of Generalized Myasthenia Gravis (gMG) in Adult Patients Who Are Anti-Acetylcholine Receptor (AChR) Antibody Positive

ZILBRYSQ® is now commercially available by prescription in the United States and dispensed by UCB's selected exclusive specialty pharmacy PANTHERx® Rare Pharmacy.ZILBRYSQ is FDA-approved as the...

Brussels , Bruxelles-capitale , Belgium , United-states , Smyrna , Izmir , Turkey , Jim-baxter , Howard-jf-jr , Laurent-schots , Daphne-teo , Antje-witte

UCB announces European Commission approval of ZILBRYSQ®▼ (zilucoplan) for the treatment of adults with generalized Myasthenia Gravis

UCB announces European Commission approval of ZILBRYSQ®▼ (zilucoplan) for the treatment of adults with generalized Myasthenia GravisEuropean approval of ZILBRYSQ® (zilucoplan) granted as an add-on to standard therapy for the treatment of generalized Myasthenia Gravis (gMG) in adult patients who are anti-acet...

Australia , Canada , Norway , Belgium , Liechtenstein , Brussels , Bruxelles-capitale , China , Iceland , Japan , Japanese , Australian